Sascha B. Fink (Magdeburg):
On Epistemic Issues of Psychedelics
In this talk, I present a cautious view of the epistemic benefits of psychedelics. I distinguish between direct and indirect benefits. Instead of directly leading to knowledge, as e.g. Letheby (2021) argued, I hold that their epistemic effects, if at all, are indirect. At most, they facilitate understanding. Based on this, I motivate a unified model that covers both good and bad cases of belief alteration under psychedelics. This view also points to three specific risks that must be addressed when implementing psychedelic-augmented therapy: The empiricist’s trap, the risk of malign openness, and pseudo-significant distractions.